![Vemurafenib / Metastasis / Protein kinase inhibitor / Cancer / Raf kinase / Skin cancer / Ipilimumab / Medicine / Melanoma / BRAF Vemurafenib / Metastasis / Protein kinase inhibitor / Cancer / Raf kinase / Skin cancer / Ipilimumab / Medicine / Melanoma / BRAF](/pdf-icon.png) Date: 2014-11-06 23:50:12Vemurafenib Metastasis Protein kinase inhibitor Cancer Raf kinase Skin cancer Ipilimumab Medicine Melanoma BRAF | | 1207: Final Decision Analytical Protocol (DAP) to guide the assessment of BRAF V600 mutation testing in patients with locally advanced or metastatic melanoma for eligibility for dabrafenib treatment
Document is deleted from original location. Use the Download Button below to download from the Web Archive.Download Document from Web Archive File Size: 1.022,85 KB
|